English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
AIM Vaccine, a Major Player in the Chinese Vaccine Industry, Successfully Listed on the Main Board of SEHK
Oct 06, 2022 19:16 HKT
AIM Vaccine Announces Global Offering Results, Offer Price of HK$16.16 per H Share
Oct 05, 2022 18:55 HKT
Bio Farma secures Multi-year Purchase Contract from UNICEF for its novel Oral Polio Vaccine type 2 (nOPV2)
Oct 04, 2022 07:00 HKT
Bio Farma to Export its Polio Vaccine After Securing Purchase Contracts from UNICEF for 2022 and 2023
Sep 30, 2022 18:00 HKT
Q&M Group awards 7 Dentists with Performance Shares, 12-year Service Agreements, and a Private Placement
Sep 30, 2022 15:00 HKT
Lepu Biopharma: Puyouheng (pucotenlimab injection) obtains approval for marketing with a new indication, Breakthrough therapy designation granted by the CDE to MRG003 for the treatment of R/M NPC
Sep 29, 2022 15:40 HKT
Taiwan Stays at the Forefront of Medical Technology
Sep 29, 2022 13:00 HKT
Claudin18.2, a shining star in gastric cancer, Transcenta's TST001 stands at the global forefront
Sep 28, 2022 19:24 HKT
Avance Clinical Wins International Health Award for Biotech CRO Services
Sep 28, 2022 16:00 HKT
AIM Vaccine Announces Proposed Listing on the Main Board of SEHK
Sep 23, 2022 17:06 HKT
Malaysian Genomics Grows Presence in Thailand
Sep 23, 2022 14:00 HKT
Agilis Robotics Targeting its Pre-B Round Fund-raising to be Completed by 2022
Sep 22, 2022 14:13 HKT
Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah
Sep 21, 2022 19:00 HKT
Sirnaomics to Present Latest Developments on siRNA Therapeutics for Cancer and GalAhead(TM) Platform Programs at the 2nd Annual Oligonucleotide Therapeutics and Delivery Conference
Sep 20, 2022 23:50 HKT
Novotech presented with Cell & Gene Excellence Award 2022 at 6th Cell & Gene Therapy World Asia Conference
Sep 15, 2022 17:00 HKT
Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook
Sep 09, 2022 21:54 HKT
Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines
Sep 09, 2022 17:00 HKT
EC Healthcare Chairman Mr. Eddy Tang Further Increases Shareholding, Exhibiting Unwavering Assurance in the Future Development of the Group
Sep 09, 2022 16:46 HKT
Dammam Valley and Arcensus GmbH to establish Saudi-German Genomic Center in Riyadh
Sep 08, 2022 23:00 HKT
Dammam Valley and Arcensus GmbH announce establishment of the Saudi-German Genomic Center in Riyadh
Sep 08, 2022 20:00 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: